|
Tuesday, July 22, 2014.
A pooled analysis reported online on July 14, 2014 in JAMA Neurology unveils an association between higher omega-3 fatty acid intake and a reduction in the risk of developing amyotrophic lateral sclerosis (ALS or Lou Gehrig’s disease), a devastating progressive disease of the central nervous system.
Kathryn C. Fitzgerald, MSc, of Harvard School of Public Health and her associates evaluated data from 522,968 men and 479,114 women enrolled in the National Institutes of Health–AARP Diet and Health Study, the Cancer Prevention Study II Nutrition Cohort, the Health Professionals Follow-up Study, the Multiethnic Cohort Study, and the Nurses’ Health Study. Dietary questionnaire responses were analyzed for omega 3 and omega 6 fatty acid intake. Over follow-up periods ranging from 9 to 24 years, 995 cases of ALS were diagnosed.
While omega 6 intake was not associated with ALS risk, subjects whose intake of omega 3 fatty acids was among the highest one-fifth of participants had a 34% lower risk of developing the disease in comparison with those among the lowest fifth. Increased alpha-linolenic acid and marine omega-3 fatty acid intake were both associated with a lower risk of the disease. Total calories consumed or percentage of energy intake from fat was not associated with risk.
“Fitzgerald and colleagues suggest that the fatty acid composition of cell plasma membranes, which could be measured in red cell membranes, might be important in modulating oxidative stress responses, excitotoxicity and inflammation, all factors that have been implicated in ALS and other neurodegenerative conditions,” noted Michael Swash, MD, of the Royal London Hospital in an accompanying editorial.
"Further research, possibly including biomarkers of polyunsaturated fatty acid intake, should be pursued to confirm these findings and to determine whether high omega 3 polyunsaturated fatty acid intake could be beneficial in individuals with ALS," Dr Fitzgerald and her associates conclude. |
|